Abstract: The objective of the present invention is to provide a composition for preventing, improving or treating respiratory diseases, comprising a Persicaria pubescens extract as an active ingredient, and the present invention was completed by confirming the effect of the Persicaria pubescens extract on activating the cell viability of human bronchial epithelial cells (BEAS-2B cells).

Abstract: A chimeric endolysin ClyRD of the present disclosure has antibacterial activity against bacteria that may cause foodborne diseases. Therefore, the chimeric endolysin ClyRD may be used as a natural controlling agent, a therapeutic agent or a preventive agent in the food industry.

Abstract: A combiner includes a first unit combiner including a first primary winding connected to a first input terminal, a second primary winding connected to a second input terminal, and a first secondary winding having first and second end portions, the first end portion connected to an output terminal, wherein the first primary winding, the second primary winding, and the first secondary winding are stacked and form a first loop, a second unit combiner including a third primary winding connected to a third input terminal, a fourth primary winding connected to a fourth input terminal, and a second secondary winding having third and fourth end portions, the third end portion connected to the output terminal, wherein the third primary winding, the fourth primary winding, and the second secondary winding are stacked and form a second loop, and a third secondary winding connected between the first and fourth end portions.

Abstract: The present invention provides a neurite outgrowth promoter for promoting neurite growth on nerve cells of a postnatal mammalian individual for use in a condition in which an effective amount of a glial cell-derived neurotrophic factor (GDNF) is not present, the neurite outgrowth promoter containing at least one protein selected from the group consisting of: GDNF family receptor ?1 (GFR?1): GFR?1 mutants having an amino acid sequence that has at least 90% sequence identity with the amino acid sequence of GFR?1, the GFR?1 mutants having neurite outgrowth activity; fusion proteins that have neurite outgrowth activity and that are obtained by fusing GFR?1 or a GFR?1 mutant with another peptide; and chemically modified proteins that have neurite outgrowth activity and that are obtained by chemically modifying one or a plurality of amino acid residues in GFR?1, a GFR?1 mutant, or a fusion protein. The present invention also provides a pharmaceutical composition for inducing nerve regeneration.

Abstract: A method of manufacturing a color-routing element, may include: generating an initial pattern; performing blurring on the initial pattern to generate a reference pattern; performing edge detection on the reference pattern to generate at least one comparison pattern reflecting a process error; performing a simulation to obtain at least one color-routing figure of merit based on the reference pattern and the at least one comparison pattern; updating the initial pattern based on a calculation result of the at least one color-routing figure of merit; generating the updated initial pattern as a target pattern of the color-routing element; and manufacturing the color-routing element based on the target pattern.

Abstract: Trans-splicing RNA (tsRNA) The invention concerns a trans-splicing RNA (tsRNA) molecule comprising at least one or multiple unstructured target binding domains complementary to at least one or multiple precursor messenger RNA (pre-mRNA) targets and adapted to prevent off-target trans-splicing by the inclusion of a safety domain; a cell or vector or therapeutic or composition or pharmaceutical composition comprising said tsRNA; and a method for killing cells or treating a disease or for imaging or for a cosmetic application using said tsRNA. The invention has use in the medical, cosmetic, and veterinary field.

Abstract: A pharmaceutical composition for treating retinitis pigmentosa that includes statin-loaded nanoparticles. The pharmaceutical composition is used in a method of treating retinitis pigmentosa involving administering to a subject in need thereof the pharmaceutical composition that includes statin-loaded nanoparticles.

Abstract: Disclosed herein is a process for recovering one or more rare earth elements from a phosphate ore that comprises the one or more rare earth elements. The process can comprise mixing the phosphate ore comprising the one or more rare earth elements with a carbonate-based flux. The process can also comprise subjecting the mixture to conditions such that the one or more rare earth elements are released from the phosphate ore and form one or more rare earth element compounds.

Abstract: A method of processing speech includes: obtaining a speech input; obtaining an instruction related to the speech input; obtaining a speech representation corresponding to the speech input; obtaining an adapter that includes speech information by fusing a pre-trained adapter with the speech representation; and obtaining a response corresponding to the instruction by inputting both the adapter that includes the speech information and the instruction to a language model, the language model generating the response based on the adapter that includes the speech model and the speech information.

Abstract: A carrageenan derivative according to the present disclosure can quickly and easily detect and label the presence of inflammation-related macrophages and, particularly, can accurately and easily identify M1-type macrophages highly associated with early inflammation. In addition, the carrageenan derivative has advantages in that it can be produced easily, environmental pollution is minimized because a small amount of organic solvent is used, and initial cost is low.

Abstract: Provided are an apparatus for diagnosing a disease and a method for diagnosing same. The apparatus includes a pump for pumping respiratory gas, a first pre-treatment portion connected to the pump and removing moisture and bad breath in the respiratory gas, and a volatile organic compound detector connected between the first pre-treatment portion and the pump and detecting volatile organic compounds in the respiratory gas.

Abstract: A form of a color-changeable plastic includes: a first conductive electrode layer; a color change layer disposed on the first conductive electrode layer, configured to cover a top surface of the first conductive electrode layer, and made of a substance that changes color depending on whether a voltage is applied; a second conductive electrode layer disposed on the color change laver, configured to cover a top surface and side surfaces of the color change layer, and configured to change the color of the color change layer with the first conductive electrode layer when the voltage is applied; and a conductive guide disposed at at least one of the first conductive electrode layer or the second conductive electrode layer, and configured to guide a movement of electrons and a color change direction of the color change layer when the voltage is applied.

Abstract: A scale thickness estimating system according an embodiment includes: a fluid temperature acquiring unit that acquires a temperature of a fluid flowing in a pipe; a flow path outer surface-temperature acquiring unit that acquires a temperature of an outer surface of the pipe; a heat flux acquiring unit that acquires a heat flux on the outer surface of the pipe; a flow path wall-thermal conductivity acquiring unit that acquires a flow path wall thermal conductivity of the pipe; a scale thermal conductivity acquiring unit that acquires a scale thermal conductivity of scale depositing on an inner surface of the pipe; and a scale thickness estimating unit that estimates a thickness of the scale based on the temperature of the fluid, the temperature of the outer surface, the heat flux, the flow path wall thermal conductivity, and the scale thermal conductivity.

Abstract: The present invention relates to a biomarker composition for diagnosing and predicting prognosis of prostate cancer, and that the detection rate and expression level of gene combination composed with AR (Androgen receptor), AR-V7 (Androgen receptor variant 7), EpCAM (Epithelial cell adhesion molecule) in blood tumor cells (CTC) isolated from patients, Epithelial cell adhesion molecule), KRT-19 (Cytokeratin 19), PSA (Prostate specific antigen), and PSMA (Prostate specific membrane antigen) in circulating tumor cells (CTCs) isolated from patients is related to the level of malignancy in prostate cancer is confirmed and thus the gene combination provides as a biomarker for prostate cancer diagnosis and a biomarker for prognosis prediction of prostate cancer.

Abstract: An electric pulse decomposition method for separating a composite material by an electric pulse, the composite material being obtained by bonding or joining a plurality of conductors to each other with an insulating member, the electric pulse decomposition method including a protrusion formation step for forming a protrusion in a specific site, on a side on which the composite material is arranged, of at least one of the plurality of conductors, and a separation step for separating the plurality of conductors in the composite material 1 by respectively bringing electrodes into contact with surfaces of the plurality of conductors and applying an electric pulse between the electrodes to destroy the insulating member. This makes it possible to separate the plurality of conductors from the composite material by making a shock wave caused by a current of the dielectric breakdown functioning as an adhesive to effectively destroy the insulating member.

Abstract: Disclosed is a rare earth complex having a rare earth ion and a phosphine oxide ligand that is coordinated with the rare earth ion and is represented by the following formula (I): wherein R1, R2, R3, R4, R5, and R6 each independently represent an alkyl group which may have a substituent.

Abstract: An electronic device includes: a display layer in which an active area and a peripheral area adjacent to the active area are defined, the display layer including a common electrode, a sensor layer disposed on the display layer and including a plurality of sensing electrodes and an antenna pattern, and a cover layer spaced apart from the sensor layer with the display layer therebetween, the cover layer having a conductivity. The peripheral area includes a first area and a second area spaced apart from the active area with the first area therebetween, and the common electrode is disposed in the active area and the first area and is spaced apart from the second area. When viewed in a plan view, a portion of the antenna pattern does not overlap the common electrode and overlaps the cover layer.

Abstract: A cell or tissue embedding device having an aqueous gel serving as an immunoisolation layer, the aqueous gel containing, as components thereof, a denatured polyvinyl alcohol resin having an activated carbonyl group and a crosslinking agent is highly capable of supplying a physiologically active substance.

Abstract: A semiconductor chip includes a chip constituent substrate having a first surface and a second surface, and including a layer containing gallium nitride. The chip constituent substrate is provided with a semiconductor element, and components constituting the semiconductor element are located more in an area adjacent to the first surface than in an area adjacent to the second surface. The chip constituent substrate is formed with a through hole penetrating the chip constituent substrate from the first surface to the second surface. The through hole defines a first opening adjacent to the first surface and a second opening adjacent to the second surface, and the first opening is larger than the second opening.

Abstract: Disclosed herein are a video decoding method and apparatus and a video encoding method and apparatus. Encoding and decoding of a target block are performed using intra-prediction. The intra-prediction is intra-prediction that uses bidirectional intra-prediction and a remaining mode. In bidirectional intra-prediction, a prediction value for a target pixel in the target block is determined based on reference pixels in two directions of bidirectional intra-prediction. In intra-prediction using a remaining mode, the remaining mode indicates remaining intra-prediction modes other than MPMs present in an MPM list.